theory clinical_30_0
imports Main

begin

typedecl entity
typedecl event

consts
  Mutation :: "entity ⇒ bool"
  Activating :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Cell :: "entity ⇒ bool"
  Promote :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  βCatenin :: "entity ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  Inhibit :: "event ⇒ bool"
  Effective :: "event ⇒ bool"
  Treat :: "event ⇒ bool"

(* Explanation 1: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
axiomatization where
  explanation_1: "∃x y z e. Mutation x ∧ Activating x ∧ CTNNB1 x ∧ Proliferation y ∧ Cell y ∧ Promote e ∧ Agent e x ∧ Patient e y ∧ βCatenin z ∧ Via e z"

theorem hypothesis:
  assumes asm: "βCatenin x ∧ Mutation y ∧ Activating y ∧ CTNNB1 y"
  (* Hypothesis: Inhibiting β-catenin may be effective in treating patients with activating CTTNB1 mutations. *)
  shows "∃x y e1 e2. Inhibit e1 ∧ βCatenin x ∧ Patient e1 x ∧ Effective e2 ∧ Treat e2 ∧ Patient e2 y ∧ Mutation y ∧ Activating y ∧ CTNNB1 y"
proof -
  (* From the premise, we have known information about β-catenin and activating mutations of CTNNB1. *)
  from asm have "βCatenin x ∧ Mutation y ∧ Activating y ∧ CTNNB1 y" by blast
  (* Explanation 1 provides a logical relation: Implies(A, C), Implies(activating mutations of CTNNB1, via β-catenin) *)
  (* Since we have activating mutations of CTNNB1, we can infer via β-catenin. *)
  then have "βCatenin x" by blast
  (* To prove the hypothesis, we need to show that inhibiting β-catenin may be effective in treating patients with activating CTNNB1 mutations. *)
  (* We assume inhibiting β-catenin as an event e1 and treating as an event e2. *)
  (* We need to show that these events are effective and involve the known entities. *)
  then have "∃e1 e2. Inhibit e1 ∧ βCatenin x ∧ Patient e1 x ∧ Effective e2 ∧ Treat e2 ∧ Patient e2 y ∧ Mutation y ∧ Activating y ∧ CTNNB1 y" sledgehammer
  then show ?thesis <ATP>
qed

end
